Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 1/20 | 0.59 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.58 |
| ▸ | BACE1 | P56817 | 9/20 | 0.53 |
| ▸ | BACE2 | Q9Y5Z0 | 2/20 | 0.52 |
| ▸ | CTSD | P07339 | 1/20 | 0.52 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.50 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.50 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.50 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.50 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.50 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.50 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.50 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.50 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.50 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30688836 | 0.99 | MMP2 (0.58) | MMP2NAALAD2BACE1BACE2CTSD | |
| SCHEMBL30099515 | 0.96 | MMP2 (0.57) | MMP2NAALAD2BACE1 | |
| SCHEMBL29531462 | 0.95 | MMP2 (0.56) | MMP2NAALAD2BACE1BACE2CTSD | |
| SCHEMBL30974450 | 0.95 | MMP2 (0.54) | MMP2NAALAD2BACE1BACE2CTSD | |
| SCHEMBL29630340 | 0.93 | MMP2 (0.64) | MMP2 | |
| SCHEMBL31730257 | 0.93 | BACE1 (0.61) | MMP2BACE1CTSD | |
| SCHEMBL29630562 | 0.92 | MMP2 (0.55) | MMP2NAALAD2BACE1BACE2CTSD | |
| SCHEMBL30974003 | 0.92 | MMP2 (0.58) | MMP2BACE1BACE2CTSD | |
| SCHEMBL31018950 | 0.92 | MMP2 (0.57) | MMP2NAALAD2BACE1BACE2CTSD | |
| SCHEMBL34464901 | 0.92 | MMP2 (0.62) | MMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025093774-A1 | GLUCAGON-LIKE PEPTIDE 1 AGONISTS | Constructive Biology Limited (GB) | 2025-05-08 | — | — | WO | claimed |
| EP-4735021-A1 | COMBINATION THERAPY | Zealand Pharma A/S (DK) | 2026-05-06 | — | — | EP | disclosed |
| WO-2025093774-A1 | GLUCAGON-LIKE PEPTIDE 1 AGONISTS | Constructive Biology Limited (GB) | 2025-05-08 | — | — | WO | disclosed |
| WO-2025003471-A1 | COMBINATION THERAPY | ZEALAND PHARMA A/S (DK) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024231312-A2 | COMBINATION THERAPY | UNION therapeutics A/S (DK) | 2024-11-14 | — | — | WO | disclosed |
| WO-2024175930-A1 | COMPOUNDS | IP2IPO INNOVATIONS LIMITED (GB) | 2024-08-29 | — | — | WO | disclosed |
| EP-4259646-A1 | NOVEL COMPOUNDS | IP2IPO Innovations Limited (GB) | 2023-10-18 | — | — | EP | disclosed |
| EP-4196495-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP Pharma GmbH (CH) | 2023-06-21 | — | — | EP | disclosed |
| WO-2022212273-A1 | METHODS AND COMPOSITIONS FOR TREATING LYSOSOMAL STORAGE DISORDERS | SANFORD HEALTH (US) | 2022-10-06 | — | — | WO | disclosed |
| WO-2022123271-A1 | NOVEL COMPOUNDS | IMPERIAL COLLEGE INNOVATIONS LIMITED (GB) | 2022-06-16 | — | — | WO | disclosed |
| US-11312974-B2 | Gene for increasing plant biomass and use therefor | KANEKA CORPORATION (JP) | 2022-04-26 | — | — | US | disclosed |
| WO-2022034062-A1 | EXENDIN-4 PEPTIDE ANALOGUES | TXP PHARMA AG (CH) | 2022-02-17 | — | — | WO | disclosed |